Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 91

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 91
---
 dated June 27, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.3
     
    Form of Placement Agency Agreement, dated June 27, 2025 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2025)

    10.4
     
    Severance Agreement, dated August 4, 2025, between INmune Bio Inc. and Raymond J. Tesi†* 

    10.5
     
    Employment Agreement, dated December 16, 2021, between INmune Bio Inc. and Cory Ellspermann†*

    31.1
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer*

    31.2
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*

    32.1
     
    Section 1350 Certification of Principal Executive Officer**

    32.2
     
    Section 1350 Certification of Chief Financial Officer**

    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith.

**Furnished herewith.

†Certain confidential information contained in this agreement
has been omitted because it is both not material and is the type that the registrant treats as private or confidential.

39

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    INmune Bio Inc